132 related articles for article (PubMed ID: 27763800)
1. The Utility of Decision Trees in Oncofertility Care in Japan.
Ito Y; Shiraishi E; Kato A; Haino T; Sugimoto K; Okamoto A; Suzuki N
J Adolesc Young Adult Oncol; 2017 Mar; 6(1):186-189. PubMed ID: 27763800
[TBL] [Abstract][Full Text] [Related]
2. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval.
Doyle JO; Richter KS; Lim J; Stillman RJ; Graham JR; Tucker MJ
Fertil Steril; 2016 Feb; 105(2):459-66.e2. PubMed ID: 26604065
[TBL] [Abstract][Full Text] [Related]
3. What factors hinder the decision-making process for women with cancer and contemplating fertility preservation treatment?
Jones G; Hughes J; Mahmoodi N; Smith E; Skull J; Ledger W
Hum Reprod Update; 2017 Jul; 23(4):433-457. PubMed ID: 28510760
[TBL] [Abstract][Full Text] [Related]
4. Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients.
Goldman RH; Racowsky C; Farland LV; Munné S; Ribustello L; Fox JH
Hum Reprod; 2017 Apr; 32(4):853-859. PubMed ID: 28166330
[TBL] [Abstract][Full Text] [Related]
5. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
[TBL] [Abstract][Full Text] [Related]
6. Oncofertility in Japan: advances in research and the roles of oncofertility consortia.
Suzuki N
Future Oncol; 2016 Oct; 12(20):2307-11. PubMed ID: 27531055
[TBL] [Abstract][Full Text] [Related]
7. Study of the Awareness of Adoption as a Family-Building Option Among Oncofertility Stakeholders in Japan.
Shiraishi E; Sugimoto K; Shapiro JS; Ito Y; Kamoshita K; Kusuhara A; Haino T; Koizumi T; Okamoto A; Suzuki N
JCO Glob Oncol; 2020; 6():. PubMed ID: 32259157
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes in cancer patients who did or did not pursue fertility preservation.
Moravek MB; Confino R; Smith KN; Kazer RR; Klock SC; Lawson AK; Gradishar WJ; Pavone ME
Fertil Steril; 2018 Feb; 109(2):349-355. PubMed ID: 29338854
[TBL] [Abstract][Full Text] [Related]
9. Oncofertility: Fertile Ground for Conflict Between Patient Autonomy and Medical Values.
Walsh SK; Ginsburg ES; Lehmann LS; Partridge AH
Oncologist; 2017 Jul; 22(7):860-863. PubMed ID: 28408620
[TBL] [Abstract][Full Text] [Related]
10. Nationwide survey of fertility preservation in patients with hematological malignancies in Japan.
Okamoto S; Fujii N; Yoshioka N; Harada M; Tanimoto M; Maeda Y; Suzuki N; Osuga Y
Int J Clin Oncol; 2021 Feb; 26(2):438-442. PubMed ID: 33068221
[TBL] [Abstract][Full Text] [Related]
11. Assisted reproductive technology use and outcomes among women with a history of cancer.
Luke B; Brown MB; Missmer SA; Spector LG; Leach RE; Williams M; Koch L; Smith YR; Stern JE; Ball GD; Schymura MJ
Hum Reprod; 2016 Jan; 31(1):183-9. PubMed ID: 26577302
[TBL] [Abstract][Full Text] [Related]
12. Cryopreserved oocyte versus fresh oocyte assisted reproductive technology cycles, United States, 2013.
Crawford S; Boulet SL; Kawwass JF; Jamieson DJ; Kissin DM
Fertil Steril; 2017 Jan; 107(1):110-118. PubMed ID: 27842997
[TBL] [Abstract][Full Text] [Related]
13. Utilization rates and results of long-term embryo cryopreservation before gonadotoxic treatment.
Dolmans MM; Hollanders de Ouderaen S; Demylle D; Pirard C
J Assist Reprod Genet; 2015 Aug; 32(8):1233-7. PubMed ID: 26174124
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with the receipt of fertility preservation services along the decision-making pathway in young Canadian female cancer patients.
Yee S
J Assist Reprod Genet; 2016 Feb; 33(2):265-80. PubMed ID: 26560157
[TBL] [Abstract][Full Text] [Related]
15. Elective single embryo transfer following in vitro fertilization.
Min JK; Hughes E; Young D; ;
J Obstet Gynaecol Can; 2010 Apr; 32(4):363-377. PubMed ID: 20500945
[TBL] [Abstract][Full Text] [Related]
16. Fertility preservation for social indications: a cost-based decision analysis.
Hirshfeld-Cytron J; Grobman WA; Milad MP
Fertil Steril; 2012 Mar; 97(3):665-70. PubMed ID: 22265038
[TBL] [Abstract][Full Text] [Related]
17. Oocyte vitrification as an efficient option for elective fertility preservation.
Cobo A; García-Velasco JA; Coello A; Domingo J; Pellicer A; Remohí J
Fertil Steril; 2016 Mar; 105(3):755-764.e8. PubMed ID: 26688429
[TBL] [Abstract][Full Text] [Related]
18. Attitudes, Beliefs, and Trends Regarding Adolescent Oncofertility Discussions: A Systematic Literature Review.
Barlevy D; Wangmo T; Elger BS; Ravitsky V
J Adolesc Young Adult Oncol; 2016 Jun; 5(2):119-34. PubMed ID: 26859796
[TBL] [Abstract][Full Text] [Related]
19. State of the art on oocyte cryopreservation in female cancer patients: A critical review of the literature.
Massarotti C; Scaruffi P; Lambertini M; Remorgida V; Del Mastro L; Anserini P
Cancer Treat Rev; 2017 Jun; 57():50-57. PubMed ID: 28550713
[TBL] [Abstract][Full Text] [Related]
20. A Study Protocol for the Australasian Oncofertility Registry: Monitoring Referral Patterns and the Uptake, Quality, and Complications of Fertility Preservation Strategies in Australia and New Zealand.
Anazodo AC; Stern CJ; McLachlan RI; Gerstl B; Agresta F; Cohn RJ; Jayasinghe Y; Wakefield CE; Daly G; Chan D; Gilbert L; Kemertzis M; Orme LM; Wand H; Viney R; Gillam L; Deans R; Jetti M; Wu J; Chapman M; Ledger W; Sullivan EA
J Adolesc Young Adult Oncol; 2016 Sep; 5(3):215-25. PubMed ID: 26981848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
